Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTristel Regulatory News (TSTL)

Share Price Information for Tristel (TSTL)

Share Price is delayed by 15 minutes
Get Live Data
387.50    -5.00 (-1.27%)
Bid:
380.00
Ask:
395.00
Spread: 15.00 (3.947%)
Market Cap: £185.99m
TSTL Live PriceLast checked at - London Stock Exchange

Intraday Tristel Share Chart

Issue of Equity

28 Mar 2023 11:30

RNS Number : 4868U
Tristel PLC
28 March 2023
 

28 March 2023

Tristel plc

 

("Tristel" or the "Company")

 

Exercise of Share Options and Total Voting Rights

 

Tristel plc (AIM: TSTL), the manufacturer of infection prevention products, announces that it has issued and allotted a total of 10,000 new ordinary shares of 1 penny each in the capital of the Company ("Ordinary Shares") following the exercise of options by employees of the Group.

Application has been made to the London Stock Exchange for the 10,000 new Ordinary Shares to be admitted to trading on AIM ("Admission") and it is expected that Admission will become effective and trading will commence at 8.00 a.m. on 31 March 2023.

 Total Voting Rights

After Admission, the total number of Ordinary Shares in issue will be 47,257,493 and the total number of voting rights will therefore be 47,257,493. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

For further information please contact:

 

Tristel plc

Tel: 01638 721 500

Paul Swinney, Chief Executive Officer

Liz Dixon, Chief Financial Officer

 

Walbrook PR Ltd

Tel: 020 7933 8780 or tristel@walbrookpr.com

Paul McManus

Mob: 07980 541 893

Lianne Applegarth

Mob: 07584 391 303

finnCap

Tel: 020 7220 0500

Geoff Nash/ Charlie Beeson (Corporate Finance)

Alice Lane (ECM)

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOEBGGDXUBDDGXI
Date   Source Headline
3rd Dec 201911:20 amRNSHolding(s) in Company
26th Nov 20197:00 amRNSForthcoming Appointment of Non-Executive Chairman
20th Nov 201910:08 amRNSIssue of Equity
18th Nov 20197:00 amRNSUpdate on MobileODT strategic investment
1st Nov 20194:00 pmRNSAudited accounts and notice of AGM
30th Oct 20192:25 pmRNSIssue of Equity
16th Oct 20197:00 amRNSFinal Results
14th Oct 201911:43 amRNSIssue of Equity
13th Sep 20193:58 pmRNSIssue of Equity
10th Sep 201910:27 amRNSHolding(s) in Company
28th Aug 20197:00 amRNSIssue of Equity
21st Aug 20197:00 amRNSInvestor results presentation
7th Aug 201910:31 amRNSIssue of Equity
31st Jul 20193:45 pmRNSHolding(s) in Company
22nd Jul 20197:00 amRNSTrading update, Acquisition & Notice of Results
12th Jun 20197:00 amRNSIssue of Equity
5th Jun 20197:00 amRNSShareholder Open Day
17th May 20191:58 pmRNSIssue of Equity
10th May 201910:26 amRNSHolding(s) in Company
1st Apr 20197:00 amRNSRegulatory approvals in China and South Korea
26th Mar 20197:00 amRNSHolding(s) in Company
6th Mar 20197:00 amRNSIssue of Equity
4th Mar 20192:31 pmRNSIssue of Equity and PDMR Dealing
1st Mar 20193:42 pmRNSDirector/PDMR Shareholding
25th Feb 20197:00 amRNSHalf-year Report
5th Feb 20197:00 amRNSDirector Appointment
14th Jan 20195:26 pmRNSDirector/PDMR Shareholding
14th Jan 201912:00 pmRNSInvestor results presentation
11th Dec 201810:49 amRNSResult of AGM
11th Dec 20187:00 amRNSAGM Statement and notice of results
19th Nov 201811:31 amRNSDirector/PDMR Shareholding
19th Nov 20187:00 amRNSAcquisition & Board Appointment
5th Nov 20188:35 amRNSIssue of Equity
17th Oct 20187:00 amRNSFinal Results
13th Sep 20187:00 amRNSNotice of Results
24th Aug 20187:00 amRNSIssue of Equity
23rd Aug 20187:00 amRNSIssue of Equity
19th Jul 20184:21 pmRNSHolding(s) in Company
19th Jul 20183:55 pmRNSHolding(s) in Company
16th Jul 20185:49 pmRNSResult of secondary placing
16th Jul 20181:53 pmRNSProposed secondary placing of Ordinary Shares
13th Jul 20187:00 amRNSTrading update & Notice of results
12th Jun 20184:39 pmRNSIssue of Equity
11th Jun 20182:37 pmRNSDirector/PDMR Shareholding
8th Jun 20187:00 amRNSShareholder Open Day
7th Jun 20188:15 amRNSIssue of Equity
1st Jun 20183:50 pmRNSDirector/PDMR Shareholdings
15th May 20188:14 amRNSHolding(s) in Company
11th May 20185:45 pmRNSDirector/PDMR Shareholding
10th May 20188:26 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.